Document is current
Any future updates will be listed below
-
Authors
Scott, Stuart https://orcid.org/0000-0001-8182-3057
Devonshire, Alison https://orcid.org/0000-0003-4960-5468
Dillon, Richard https://orcid.org/0000-0001-9333-5296
Thiede, Christian
Cross, Nicholas C. P. https://orcid.org/0000-0001-5481-2555
White, Helen E.
Lo Cascio, Leandro
Mokretar, Katya
Potter, Nicola https://orcid.org/0000-0002-8256-9350
Hourigan, Christopher S.
Radich, Jerald https://orcid.org/0000-0002-1618-230X
Corner, Adam
Laloux, Véronique
Halliday, Gemma
Dilks, Daniel
Morrison, Tom
Gilmour, Katelyn
Cartwright, Ashley
Whitby, Liam
- License Information
-
More Information
Article History
Received: 21 February 2024
Revised: 5 April 2024
Accepted: 30 April 2024
First Online: 23 May 2024
Competing interests
: Whilst the diverse composition of the panel brought a breadth of expertise and perspectives, it also introduced potential conflicts of interest, particularly regarding the commercial providers. These entities may have a vested interest in the outcomes of the advisory panel due to their affiliations and the nature of their businesses. Each member has disclosed their respective affiliations with commercial bodies. The discussion was led by individuals from non-commercial entities and all recommendations and findings have been derived through consensus and with the commitment to advancing clinical and laboratory practice. These disclosures have been made explicit to uphold transparency and integrity in the reporting of the panel’s findings.
